Physician
Premier Health Specialists INC
Premier Health Specialists INC was paid $31.13M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is J2350, Injection, ocrelizumab, 1 mg — 24% of everything it billed.
33Billing provider infoPREMIER HEALTH SPECIALISTS INC
MORAINE, OH 45439
MORAINE, OH 45439
33aNPI1194958223assigned 08/24/2009
33bProvider typeCardiovascular Disease Physician
28Total paid$31.13M
24GClaims722,448
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in Ohio
Rank by total paid#1 of 111
Median peer was paid$9K
This provider vs. median3,438×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 111,924 | $2.99M | |
| 2019 | 102,006 | $3.20M | |
| 2020 | 87,924 | $3.64M | |
| 2021 | 99,061 | $5.20M | |
| 2022 | 103,384 | $7.85M | |
| 2023 | 130,195 | $5.17M | |
| 2024incomplete | 87,954 | $3.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2350 | Injection, ocrelizumab, 1 mg | 24% | 294 | 237 | $7.61M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 122,163 | 102,668 | $5.42M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 64,455 | 56,871 | $3.17M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5.0% | 223,510 | 191,635 | $1.56M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4.6% | 2,720 | 1,100 | $1.45M |
| J2323 | Injection, natalizumab, 1 mg | 4.5% | 239 | 212 | $1.41M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.1% | 25,915 | 23,481 | $953K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.5% | 9,272 | 8,704 | $788K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.4% | 16,539 | 15,404 | $745K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.4% | 32,822 | 13,888 | $744K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 13,567 | 11,434 | $570K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.6% | 9,773 | 9,379 | $511K |
158 more codes
| 59025 | Fetal non-stress test | 1.6% | 19,273 | $501K |
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 8,503 | $440K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 5,018 | $390K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.1% | 11,265 | $336K |
| 76801 | <1% | 7,227 | $270K | |
| 76830 | Ultrasound, transvaginal | <1% | 4,976 | $228K |
| 76813 | <1% | 4,275 | $217K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 4,595 | $217K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,958 | $214K |
| 20610 | <1% | 4,452 | $180K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,489 | $172K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,605 | $160K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 4,511 | $154K |
| 93000 | <1% | 13,160 | $148K | |
| 99223 | Prolong inpt eval add15 m | <1% | 2,304 | $148K |
| 95886 | <1% | 2,901 | $137K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 9,267 | $135K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,443 | $131K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,950 | $129K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,307 | $124K |
| 93295 | <1% | 3,268 | $110K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,443 | $96K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 3,066 | $92K |
| 64612 | <1% | 701 | $89K | |
| 93296 | <1% | 6,677 | $86K | |
| 95720 | <1% | 589 | $66K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 466 | $61K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 908 | $57K |
| 20611 | <1% | 1,116 | $56K | |
| 93016 | <1% | 3,108 | $53K | |
| 81025 | <1% | 6,594 | $46K | |
| 64616 | <1% | 728 | $45K | |
| 99254 | <1% | 569 | $41K | |
| 99241 | <1% | 1,629 | $37K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,667 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,259 | $35K |
| 99205 | Prolong outpt/office vis | <1% | 387 | $35K |
| 64615 | <1% | 303 | $34K | |
| 93018 | <1% | 3,182 | $32K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,290 | $32K |
| 99243 | <1% | 684 | $30K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,874 | $29K |
| 93970 | <1% | 1,152 | $27K | |
| 93297 | <1% | 2,085 | $27K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 451 | $25K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 588 | $25K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 271 | $21K |
| 73562 | <1% | 1,051 | $20K | |
| 11721 | <1% | 1,395 | $20K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,762 | $20K |
| 93971 | <1% | 1,189 | $19K | |
| 95910 | <1% | 190 | $17K | |
| 95816 | <1% | 704 | $17K | |
| 93298 | <1% | 889 | $17K | |
| 93294 | <1% | 1,070 | $17K | |
| 99255 | <1% | 180 | $17K | |
| 99253 | <1% | 314 | $16K | |
| 96415 | <1% | 338 | $15K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,426 | $14K |
| 73630 | <1% | 711 | $12K | |
| 95951 | <1% | 123 | $12K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 274 | $12K |
| 95819 | <1% | 546 | $11K | |
| 99078 | <1% | 276 | $11K | |
| 81002 | <1% | 4,045 | $10K | |
| 95718 | <1% | 120 | $10K | |
| 72110 | <1% | 284 | $9K | |
| 43775 | <1% | 16 | $9K | |
| 95911 | <1% | 93 | $9K | |
| 76820 | <1% | 360 | $8K | |
| 96367 | <1% | 347 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 503 | $7K |
| 99234 | <1% | 110 | $6K | |
| 76506 | <1% | 217 | $6K | |
| 64405 | <1% | 87 | $5K | |
| 99242 | <1% | 156 | $5K | |
| 99459 | <1% | 247 | $4K | |
| 99218 | <1% | 107 | $4K | |
| 73564 | <1% | 230 | $4K | |
| 22853 | <1% | 13 | $4K | |
| 54150 | <1% | 67 | $4K | |
| 93793 | <1% | 794 | $3K | |
| 95909 | <1% | 41 | $3K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 188 | $3K |
| 61783 | <1% | 26 | $3K | |
| 68761 | <1% | 90 | $3K | |
| 20550 | <1% | 108 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 375 | $2K |
| 83861 | <1% | 161 | $2K | |
| 99245 | <1% | 30 | $2K | |
| 73610 | <1% | 121 | $2K | |
| 64644 | <1% | 43 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 67 | $2K |
| 73030 | <1% | 81 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 733 | $2K |
| 96127 | <1% | 251 | $2K | |
| 99343 | <1% | 29 | $2K | |
| 85610 | <1% | 786 | $2K | |
| 99442 | <1% | 74 | $2K | |
| 93285 | <1% | 47 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 29 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 78 | $1K |
| 59430 | <1% | 13 | $1K | |
| 93356 | <1% | 146 | $1K | |
| 73502 | <1% | 84 | $1K | |
| 93312 | <1% | 13 | $1K | |
| 93880 | <1% | 51 | $1K | |
| 87210 | <1% | 229 | $1K | |
| 99251 | <1% | 42 | $1K | |
| 96101 | <1% | 18 | $976.31 | |
| 95908 | <1% | 16 | $966.54 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 180 | $878.16 |
| 51798 | <1% | 136 | $855.08 | |
| 99219 | <1% | 12 | $803.40 | |
| 73560 | <1% | 41 | $760.61 | |
| 99443 | <1% | 26 | $749.00 | |
| 99349 | <1% | 35 | $727.58 | |
| 90686 | <1% | 51 | $704.23 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 12 | $683.16 |
| 99221 | <1% | 28 | $620.17 | |
| 97597 | <1% | 108 | $590.78 | |
| 93299 | <1% | 45 | $541.73 | |
| 64450 | <1% | 96 | $505.15 | |
| 90870 | <1% | 23 | $468.82 | |
| 72050 | <1% | 13 | $365.56 | |
| 93308 | <1% | 23 | $355.96 | |
| 72114 | <1% | 15 | $355.27 | |
| 99201 | <1% | 31 | $330.92 | |
| 72100 | <1% | 15 | $308.57 | |
| 73130 | <1% | 13 | $266.52 | |
| 93320 | <1% | 13 | $212.08 | |
| 20553 | <1% | 64 | $201.87 | |
| 94060 | <1% | 16 | $158.52 | |
| 99406 | <1% | 14 | $120.74 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 520 | $106.10 |
| 94726 | <1% | 17 | $67.54 | |
| 94729 | <1% | 17 | $63.78 | |
| 85018 | <1% | 52 | $59.76 | |
| 93325 | <1% | 13 | $46.19 | |
| 3017F | 0% | 705 | $0.00 | |
| 99024 | 0% | 2,471 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 291 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 624 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 379 | $0.00 |
| 1036F | 0% | 875 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 14 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 12 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 15 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,501 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 481 | $0.00 |
| 4040F | 0% | 142 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 83 | $0.00 |
| 20936 | 0% | 27 | $0.00 | |
| 96102 | 0% | 17 | $0.00 | |
| 4004F | 0% | 14 | $0.00 | |
| 20930 | 0% | 44 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 40 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMICHEL, DARLENE (SYSTEMS SUPPORT ANALYST)
| Provider | Location | Paid |
|---|---|---|
| Samaritan Family Care INC | Moraine, OH | $3.86M |
| Upper Valley Professional Corporation | Troy, OH | $3.04M |
| Uvpc Specialists INC. | Troy, OH | $2.14M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.